ESR1 and breast carcinoma: However, estrogenic activity induced by binding of phytoestrogens to estrogen receptors can cause endocrine disruption, resulting in side effects including uterine disease, breast cancer, or polycystic ovary syndrome in middle-aged women [52,53].